Business context and reporting period
Markel Corporation’s fiscal-year 2016 Form 10-K covers the year ended December 31, 2016, with 2015 comparisons. Although the request identifies Markel Group Inc., the registrant named in this historical filing is Markel Corporation. Its businesses include specialty insurance and reinsurance, Markel Ventures industrial and service companies, and Markel CATCo investment management.
Key financial metrics
| Metric | 2016 | 2015 |
|---|---|---|
| Total operating revenues | $5.612 billion | $5.370 billion |
| Earned premiums | $3.866 billion | $3.824 billion |
| Net income to shareholders | $455.7 million | $582.8 million |
| Diluted earnings per share | $31.27 | $41.74 |
| Operating cash flow | $534.6 million | $651.2 million |
| Invested assets | $19.1 billion | $18.2 billion |
| Senior long-term and other debt | $2.575 billion | $2.239 billion |
| Shareholders’ equity | $8.461 billion | $7.834 billion |
| Book value per share | $606.30 | $561.23 |
The consolidated combined ratio was 92%, versus 89% in 2015; underwriting profit was $316.5 million, down from $429.7 million. A ratio below 100% indicates underwriting profit. Net investment income rose to $373.2 million from $353.2 million; net realized investment gains fell to $65.1 million from $106.5 million. Taxable-equivalent total investment return was 4.4%, compared with negative 0.7% in 2015. The investment yield was 2.4%.
By underwriting segment, 2016 gross premium volume and underwriting profit were: U.S. Insurance, $2.635 billion and $152.7 million; International Insurance, $1.120 billion and $47.2 million; Reinsurance, $1.041 billion and $106.8 million. Their combined ratios were 93%, 94%, and 87%, respectively.
At year-end, assets were $25.875 billion, cash and cash equivalents were $1.739 billion, and restricted cash was $346.4 million. The company had no borrowings outstanding under its $300 million revolving credit facility and reported compliance with its covenants. Debt-to-capital was 23%, versus 22%. Operating cash flow declined; investing activities used $1.545 billion, primarily reflecting net investment purchases and increased short-term investments. The filing states the company believes it has sufficient liquidity to meet capital needs.
Material changes versus the prior comparable period
- Revenue increased 4.5%, but net income to shareholders decreased 22%, principally due to weaker underwriting results, lower realized investment gains, and a $44.1 million loss on early debt extinguishment. Higher non-insurance results partly offset these factors.
- Underwriting profit fell about 26%; the combined ratio worsened by three percentage points. Favorable prior-year reserve development was $505.2 million, compared with $627.8 million in 2015.
- Gross premium volume grew 4% to $4.797 billion. U.S. Insurance and Reinsurance grew, while International Insurance declined, partly from foreign exchange movements and lower marine and energy volume. Earned premiums rose about 1%.
- Comprehensive income to shareholders rose to $667.0 million from $232.7 million, aided by a $242.2 million after-tax increase in unrealized investment gains; 2015 had a $320.5 million decrease.
- Book value per share increased 8%, versus 3% in 2015. The five-year compound annual growth rate was 11%.
- Markel Ventures revenue was $1.215 billion and net income to shareholders was $56.2 million, compared with $1.048 billion and $11.0 million. EBITDA, a non-GAAP measure, was $165.1 million versus $91.3 million.
Outlook, management commentary, risks and unusual items
- Management described the overall property and casualty market as soft, with pricing pressure across many lines. It said it would pursue rate increases in 2017 where possible and would not write business when pricing fails to meet underwriting profit targets. No formal earnings or revenue guidance is provided.
- Management said additional favorable prior-year reserve development in 2017 was possible but cautioned against relying on the trend. Its estimated reasonably likely range for 2017 reserve movement was a deficiency of less than 1% (about $50 million) to a redundancy of approximately 6% (about $450 million) of year-end 2016 net reserves.
- 2016 catastrophe losses included $22.1 million from Canadian wildfires and $46.6 million from Hurricane Matthew. Medical malpractice and specified medical lines had $71.2 million of adverse prior-year development, attributed to rising claim frequencies and payments in certain classes; corrective actions were taken.
- Key exposures include reserve-estimation uncertainty, long-tail and asbestos/environmental claims, catastrophe severity and climate-related losses, reinsurance counterparty collections, equity-market concentration, interest rates, competition and soft-market pricing, regulation, cyber risk, international currency and political risk, and Brexit-related uncertainty.
- The investment portfolio includes $4.746 billion in equity securities; its ten largest holdings accounted for 44% of that portfolio. Management disclosed that a hypothetical 35% equity-price decline would reduce shareholders’ equity by an estimated 13.1%.
- During 2016 the company issued $500 million of 5.0% notes due 2046 and repurchased portions of higher-coupon notes, recognizing the $44.1 million extinguishment loss. A $90.6 million principal balance of 7.20% notes was due in April 2017. A February 2017 agreement to acquire SureTec Financial for approximately $250 million was expected to close in the first half of 2017, subject to conditions and regulatory approvals.
- A fourth-quarter goodwill impairment of $18.7 million reduced goodwill for an industrial manufacturing reporting unit to zero, following oil-price-related weakness. The filing also reports $33.2 million of 2016 compensation expense tied to CATCo performance and retention arrangements.
- KPMG issued unqualified opinions on the financial statements and internal controls; management reported effective internal control over financial reporting.
Important facts for investors to verify
- Review reserve adequacy and the composition and persistence of the $505.2 million favorable prior-year development, especially medical malpractice/specifed medical adverse trends and long-tail casualty experience.
- Check whether underwriting margins and pricing improve or deteriorate in the continued soft market, and whether the 2017 reserve-development range is borne out.
- Assess investment concentration and sensitivity to equity-market declines and rising interest rates, as well as the effect of accounting changes that move equity fair-value changes into net income beginning in 2018.
- Confirm the refinancing/retirement of the notes due in April 2017, debt-service capacity, and the impact of the SureTec acquisition on capital and liquidity.
- Monitor reinsurance recoverable collectability: the ten largest reinsurer groups represented 67% of recoverables, and the largest group represented 15%.
- Track Brexit’s effect on access to European insurance markets, any required entity restructuring, and the associated costs or business disruption.